Neil Kumar - Feb 16, 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
CEO and President, Director
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Feb 16, 2024
Transactions value $
-$1,783,178
Form type
4
Date filed
2/21/2024, 04:03 PM
Previous filing
Nov 20, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +102K +2.12% 4.92M Feb 16, 2024 Direct F1
transaction BBIO Common Stock Tax liability -$1.78M -47.9K -0.97% $37.21 4.87M Feb 16, 2024 Direct F2
holding BBIO Common Stock 1.01M Feb 16, 2024 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. F3
holding BBIO Common Stock 996K Feb 16, 2024 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -5.13K -50% $0.00 5.13K Feb 16, 2024 Common Stock 5.13K Direct F1, F4
transaction BBIO Restricted Stock Units Options Exercise $0 -2.39K -20% $0.00 9.58K Feb 16, 2024 Common Stock 2.39K Direct F1, F5
transaction BBIO Restricted Stock Units Options Exercise $0 -61.2K -100% $0.00* 0 Feb 16, 2024 Common Stock 61.2K Direct F1, F6
transaction BBIO Restricted Stock Units Options Exercise $0 -33.5K -7.69% $0.00 403K Feb 16, 2024 Common Stock 33.5K Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 102,249 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4 The RSUs vested with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F5 The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F6 The RSUs vested with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares vested on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F7 The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.